[{"internal_id": 140608663, "Award ID": "G2199ONDCP09A", "Award Amount": 275000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-09-21", "CFDA Number": "95.007", "Description": "INITIATIVE ACTIVITIES TO SUPPORT THE EMERGENCY DEPARTMENT SUBSTANCE USE SURVEILLANCE SYSTEM.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e04c3b49-28c8-efb6-f8ea-b4c853900d6f-C", "generated_internal_id": "ASST_NON_G2199ONDCP09A_1127"}, {"internal_id": 140608665, "Award ID": "G2199ONDCP06A", "Award Amount": 3000000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2021-09-09", "CFDA Number": "95.007", "Description": "COMBATING OVERDOSE THROUGH COMMUNITY-LEVEL INTERVENTION INITIATIVES.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d97e08b8-c59c-946b-ad6e-1bef5e5b6a1e-C", "generated_internal_id": "ASST_NON_G2199ONDCP06A_1127"}, {"internal_id": 110840213, "Award ID": "G2099ONDCP09A", "Award Amount": 149999.54, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-22", "CFDA Number": "95.007", "Description": "SUPPORT OF INITIATIVES DESIGNED TO IMPLEMENT THE EMERGENCY DEPARTMENT SUBSTANCE USE SURV.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e04c3b49-28c8-efb6-f8ea-b4c853900d6f-C", "generated_internal_id": "ASST_NON_G2099ONDCP09A_1127"}, {"internal_id": 110840217, "Award ID": "G2099ONDCP06A", "Award Amount": 1980108.63, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-09-08", "CFDA Number": "95.007", "Description": "COMBATING OPIOID OVERDOSE THROUGH COMMUNITY LEVEL INTERVENTION INITIATIVE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d97e08b8-c59c-946b-ad6e-1bef5e5b6a1e-C", "generated_internal_id": "ASST_NON_G2099ONDCP06A_1127"}, {"internal_id": 86247505, "Award ID": "G1999ONDCP06B", "Award Amount": 3445743.79, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-16", "CFDA Number": "95.007", "Description": "SUPPORT OF INITIATIVES DESIGNED TO COMBAT OPIOID OVERDOSE THROUGH COMMUNITY-LEVEL INTERVENTION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d97e08b8-c59c-946b-ad6e-1bef5e5b6a1e-C", "generated_internal_id": "ASST_NON_G1999ONDCP06B_1127"}, {"internal_id": 86247504, "Award ID": "G1999ONDCP06A", "Award Amount": 1000000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2019-09-16", "CFDA Number": "95.007", "Description": "SUPPORT OF INITIATIVES DESIGNED TO COMBAT OPIOID OVERDOSE THROUGH COMMUNITY LEVEL INTERVENTION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d97e08b8-c59c-946b-ad6e-1bef5e5b6a1e-C", "generated_internal_id": "ASST_NON_G1999ONDCP06A_1127"}, {"internal_id": 73784150, "Award ID": "G1899ONDCP06B", "Award Amount": 3330903.06, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-26", "CFDA Number": "95.007", "Description": "COMBATING OPIOID OVERDOSE THROUGH COMMUNITY-LEVEL INTERVENTION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d97e08b8-c59c-946b-ad6e-1bef5e5b6a1e-C", "generated_internal_id": "ASST_NON_G1899ONDCP06B_1127"}, {"internal_id": 69815428, "Award ID": "G1899ONDCP06A", "Award Amount": 0.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2018-09-26", "CFDA Number": "95.007", "Description": "COMBATING OPIOID OVERDOSE THROUGH COMMUNITY-LEVEL INTERVENTION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d97e08b8-c59c-946b-ad6e-1bef5e5b6a1e-C", "generated_internal_id": "ASST_NON_G1899ONDCP06A_1127"}, {"internal_id": 48671681, "Award ID": "G1799ONDCP07A", "Award Amount": 100000.0, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-21", "CFDA Number": "95.007", "Description": "SUPPORT OF INITIATIVES FOR DRUG EARLY WARNING SIGNALS FROM HIGH RISK POPULATIONS BY RE-TESTING BIOLOGICAL SAMPLES.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e04c3b49-28c8-efb6-f8ea-b4c853900d6f-C", "generated_internal_id": "ASST_NON_G1799ONDCP07A_1127"}, {"internal_id": 81884894, "Award ID": "G1799ONDCP06B", "Award Amount": 1931497.8, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-09-26", "CFDA Number": "95.007", "Description": "COMBATING OPIOID OVERDOSE THROUGH COMMUNITY-LEVEL INTERVENTION.", "Place of Performance Country Code": "USA", "Place of Performance State Code": null, "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d97e08b8-c59c-946b-ad6e-1bef5e5b6a1e-C", "generated_internal_id": "ASST_NON_G1799ONDCP06B_1127"}]